Navigation Links
Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor

ly significantly less (p < 0.05) than mice treated with either capecitabine alone (461.0 mm3 +/- 50.4) or mice treated with LV, 5-FU and capecitabine (447.8 mm3 +/- 46.5). Consistent with superior inhibition of tumor growth, treatment with CoFactor, 5-FU and capecitabine also prolonged survival compared to the other treatment regimens. The median survival of CoFactor, 5-FU and capecitabine treated mice (60 days) was statistically significantly longer (p < 0.05) than capecitabine alone (38 days) and LV, 5-FU and capecitabine (39 days). Importantly, the increased tumor inhibition and survival benefits of treatment with CoFactor, 5-FU and capecitabine did not come at the cost of added toxicity. Treatment with CoFactor, 5-FU and capecitabine caused less severe weight loss than all other drug treatments, including capecitabine alone. These results suggest a hybrid treatment regimen, consisting of a CoFactor and 5-FU treatment backbone coupled with capecitabine, might confer improvements in antitumor activity and survival without corresponding increases in systemic toxicity in patients with colorectal cancer. The Company plans to pursue further testing of this CoFactor treatment regimen.

About CoFactor

CoFactor (ANX-510) is a folate-based biomodulator drug designed to replace leucovorin as the preferred method to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy 5-fluorouracil (5-FU). In comparison to leucovorin, CoFactor creates more stable binding of the active form of 5-FU to the target enzyme, thymidylate synthase (TS). CoFactor bypasses the metabolic pathway required by leucovorin to deliver the active form of folate, allowing 5-FU to work more effectively. CoFactor is in Phase 3 and Phase 2b clinical trials for the treatment of metastatic colorectal cancer, as well as in a Phase 2 clinical trial for the treatment of advanced breast cancer.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/29/2015)... -- Fifty groups representing 500,000 patients, doctors, and researchers will ... AllTrials campaign in the US. The global campaign calls ... be registered and the results from it reported. ... explains: "Patients want the treatments that are best for ... Unfortunately, we now know that around half of all ...
(Date:7/29/2015)... 2015  Medical Care Alert, a leading national provider ... availability of its new HOME & AWAY ELITE mobile ... neck or on the hip, the small two-ounce pendant ... USA using the AT&T Wireless network. ... in mobile and automatic fall detection medical alert systems. ...
(Date:7/29/2015)... 29, 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ... revenue interest assignment agreement (the "Agreement") in which it ... ARIA ) with up to $200 million in revenue ... revenues of Iclusig ® (ponatinib).  Funding of the ... of $50 million each, with the initial amount having ...
Breaking Medicine Technology:Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 2New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 3New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5
... FAIRFAX, Va., Oct. 12 General Dynamics Information Technology, ... GD ), has been awarded a contract to support ... modernization of current Army medical facilities and transition to ... contract, one of five awarded by the U.S. Army ...
... and Luminex Corporation Partner to Develop Automated Newborn... -- MANNEDORF, Switzerland and AUSTIN, Texas, Oct. 12 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Medicine Technology:General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 3Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 2Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 3Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 4Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 5Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 6Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 7Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 8Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution 9
(Date:7/29/2015)... ... 2015 , ... According to The Spirits Business on July 16th, ... for stimulating and perpetuating alcohol use disorders. Humans have the same gene, which is ... academy of Sciences, and has given researchers inklings to explore Rsu1 in humans to ...
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 ... ... reported e-cigarette shops are anticipating testing regulations imposed by the FDA for nicotine ... lows, but use of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Southwest Michigan, changed its name in July to Kalamazoo Strength & Conditioning. , ... http://www.kalamazoosc.com , and “reflects the evolution of our training center over the past ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley skin doctor ... a limited time only, patients can get the complete treatment process with a 10 ... prefer a non-invasive treatment and have loose or sagging skin. , As the ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year in a row, the ... of the 50 fastest growing companies in Jacksonville. This annual list is compiled by ... 16th, a team of Vast Bridges staffers were on hand to receive the award ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Vast Bridges Continues Its Swift Growth 2
... treat bacterial infection has been recalled by the Chinese Ministry ... injection. ,The injection produced by a company in ... death of a six-year-old girl from Harbin. The girl ... clindamycin phosphate glucose injection, but developed high fever within 20 ...
... UK College of Nursing said that smokers who smoke more ... in quitting smoking. ,According to the study, published ... not only do smokers who suffer from chronic pain tend ... suggest that smoking may cause patients to not do well ...
... is a land in the grip of a dangerous alcohol ... of adults binge drink over double the daily recommended limit ... in the north-east and north-west parts of the country almost ... one or more drinking bouts each week. This is equivalent ...
... functions in reproduction than merely being a carrier of ... from fertile men contains a multitude of hormones//. Some ... Some other hormones are reported to have a role ... Burch, thinks human males have evolved the concoction as ...
... following the Alder Hey body parts scandal are stifling ... on approaching study volunteers, excessive paperwork, and seemingly arbitrary ... from getting studies up and running. ,Jenny ... a disaster and it is absolutely not in the ...
... large supermarkets in UK, namely Tesco, Sainsbury’s, and Asda have ... ,The supermarkets have announced deadlines for removing hydrogenated oil, which ... products. It has been explained that trans fatty acid or ... the risk of obesity and heart disease, and has also ...
Cached Medicine News:Health News:Can Smoking Relieve Pain? 2Health News:England in the Grip of Dangerous Alcohol Addiction 2Health News:Medical researchers being stifled by NHS Red tape 2Health News:Supermarket Chains In UK To Ban The Use Of Trans Fats 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: